In prostate cancer pathways (PI3K-Akt, MAPK), key targets like AR, PIK3CA, and TP53 are co-regulated by multiple components, indicating synergies via shared targets or pathways. The gene discussed is PIK3CA; the disease is prostate carcinoma.